development | e-Asfalistiki
Spain: EIB provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases
EIB support to develop breakthrough treatments to address orphan neurodegenerative diseases with high unmet medical needs Focus on Minoryx’s lead asset, leriglitazone, a novel, disease-modifying PPAR-γ agonist Venture debt operation…
Finland: EIB lends EUR 40m to Fazer Group for research and development
- European Investment Bank (EIB) finances Fazer’s research and development activities, including the construction of an innovative xylitol manufacturing facility. - EUR 40m loan for activities to be rolled out…
Poland: EIB boost for research and development
- A EUR 305m loan agreement with the Polish government will help national scientific centres in Warsaw and Krakow fund projects in both early-stage and applied research activities- Fifth EIB…
